The Definition and Significance of Cucurbitacin B a STAT3 Inhibitors Response

被引：0
|
作者：
Chan, Tak [1 ]
机构：
[1] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
CANCER LETTERS | 2013年 / 328卷 / 01期
关键词：
D O I：
10.1016/j.canlet.2012.01.032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of STAT3 and phosphorylated STAT3 in human soft tissue tumors - a clinicopathological analysis
    David, Diana
    Rajappan, Lakshmy M.
    Balachandran, Krishna
    Thulaseedharan, Jissa V.
    Nair, Asha S.
    Pillai, Radhakrishna M.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [22] Cucurbitacin B Inhibits the Malignancy of Esophageal Carcinoma through the KIF20A/JAK/STAT3 Signaling Pathway
    Liu, Chao
    Ji, Jian
    Li, Chenglin
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (01): : 275 - 289
  • [23] Cucurbitacin-D inhibits hepatic gluconeogenesis through activation of Stat3 signaling
    Pan, Jia-Yan
    Zhang, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2582 - +
  • [24] Tetrapodal Stat3 inhibitors offer potent disruption of Stat3 in vitro and in whole cell assays
    Page, Brent D. G.
    Schimmer, Aaron
    Turkson, James
    Gunning, Patrick T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [25] STAT3 Inhibitor, Cucurbitacin I, Synergies with Crizotinib in Vitro Preclinical Models of Neuroblastoma
    Hiwatari, Mitsuteru
    Seki, Masafumi
    Sekiguchi, Masahiro
    Kimura, Shun-suke
    Kubota, Yasuo
    Watanabe, Kentaro
    Oka, Akira
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S103 - S104
  • [26] Erratum: Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity
    J Sun
    M A Blaskovich
    R Jove
    S K Livingston
    D Coppola
    S M Sebti
    Oncogene, 2008, 27 : 1344 - 1344
  • [27] Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells
    Zhang, Meng
    Bian, Zhi-Gang
    Zhang, Yi
    Wang, Jia-He
    Kan, Liang
    Wang, Xin
    Niu, Hui-Yan
    He, Ping
    MOLECULAR MEDICINE REPORTS, 2014, 10 (06) : 2905 - 2911
  • [28] Small Molecule Inhibitors of STAT3 for Cancer Therapy
    Zhao, M.
    Jiang, B.
    Gao, F-H.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (26) : 4012 - 4018
  • [29] STAT3 INHIBITORS ATTENUATE THE SEVERITY OF EXPERIMENTAL NEC
    Scott, B.
    Chaaban, H.
    Lawrence, S.
    Eckert, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 477 - 478
  • [30] The development of peptide-based inhibitors of Stat3α
    Ren, Zhiyong
    Coleman, David R.
    Cabell, Larry A.
    McMurray, John S.
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 550 - 552
12345